VYANT BIO INC (VYNT) Stock Price, Quote, News and Overview
NASDAQ:VYNT - Nasdaq - US92942V2088 - Common Stock - Currency: USD
VYNT Quote, Performance and Key Statistics
0.26
-0.08 (-23.51%)
The current stock price of VYNT is 0.26 USD. In the past month the price decreased by -52.13%. In the past year, price decreased by -92.17%.
VYNT Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 19.97 | 357.10B | ||
| AMGN | AMGEN INC | 15.29 | 162.72B | ||
| GILD | GILEAD SCIENCES INC | 23.85 | 137.00B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 1669.79 | 124.40B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.34 | 76.56B | ||
| ARGX | ARGENX SE - ADR | N/A | 39.16B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 32.32B | ||
| BNTX | BIONTECH SE-ADR | N/A | 28.77B | ||
| ONC | BEIGENE LTD-ADR | N/A | 27.25B | ||
| NTRA | NATERA INC | N/A | 21.43B | ||
| BIIB | BIOGEN INC | 8.54 | 20.49B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 16.31B |
Related stock screener links
About VYNT
Company Profile
Vyant Bio, Inc. is a biotechnology company, which engages in drug discovery for complex neurodevelopmental and neurodegenerative disorders. The company is headquartered in Cherry Hill, New Jersey and currently employs 8 full-time employees. The company went IPO on 2013-04-10. The firm is engaged in combining sophisticated data science capabilities with highly functional human cell derived disease models. Its central nervous system (CNS) drug discovery platform combines human-derived organoid models of brain disease, scaled biology, and machine learning. The Company’s platform is designed to elucidate disease pathophysiology; formulate key therapeutic hypotheses; identify and validate drug targets, cellular assays, and biomarkers to guide candidate molecule selection, and guide clinical trial patient selection and trial design. The Company’s programs are focused on identifying repurposed and novel small molecule clinical candidates for rare CNS genetic disorders, including Rett Syndrome (Rett), CDKL5 Deficiency Disorders (CDD) and familial Parkinson’s Disease (PD).
Company Info
VYANT BIO INC
2 Executive Campus, 2370 State Route 70, Suite 310
Cherry Hill NEW JERSEY 07070 US
CEO: John A. Roberts
Employees: 8
Company Website: https://www.vyantbio.com/
Phone: 12015289200.0
VYANT BIO INC / VYNT FAQ
What is the stock price of VYANT BIO INC today?
The current stock price of VYNT is 0.26 USD. The price decreased by -23.51% in the last trading session.
What is the ticker symbol for VYANT BIO INC stock?
The exchange symbol of VYANT BIO INC is VYNT and it is listed on the Nasdaq exchange.
On which exchange is VYNT stock listed?
VYNT stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for VYANT BIO INC stock?
7 analysts have analysed VYNT and the average price target is 5.1 USD. This implies a price increase of 1861.54% is expected in the next year compared to the current price of 0.26. Check the VYANT BIO INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is VYANT BIO INC worth?
VYANT BIO INC (VYNT) has a market capitalization of 1.63M USD. This makes VYNT a Nano Cap stock.
How many employees does VYANT BIO INC have?
VYANT BIO INC (VYNT) currently has 8 employees.
Is VYANT BIO INC (VYNT) expected to grow?
The Revenue of VYANT BIO INC (VYNT) is expected to decline by -100% in the next year. Check the estimates tab for more information on the VYNT EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy VYANT BIO INC (VYNT) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of VYNT, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of VYNT, evaluating the profitability, health, valuation and growth aspects
- VYANT BIO INC (VYNT) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- VYANT BIO INC (VYNT) Sales and EPS estimates to see what analysts future expectations are.
- VYANT BIO INC (VYNT) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- VYANT BIO INC (VYNT) Insider and Institutional Ownership to learn about the owners and their transactions.
- VYANT BIO INC (VYNT) Stock Chart to make your own analysis
- VYANT BIO INC (VYNT) Latest news and press-releases to stay up to date.
Does VYANT BIO INC (VYNT) stock pay dividends?
VYNT does not pay a dividend.
When does VYANT BIO INC (VYNT) report earnings?
VYANT BIO INC (VYNT) will report earnings on 2023-08-14.
What is the Price/Earnings (PE) ratio of VYANT BIO INC (VYNT)?
VYANT BIO INC (VYNT) does not have a PE ratio as the earnings reported over the last twelve months were negative (-3.91).
VYNT Technical Analysis
VYNT Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to VYNT. VYNT may be in some trouble as it scores bad on both profitability and health.
VYNT Financial Highlights
Over the last trailing twelve months VYNT reported a non-GAAP Earnings per Share(EPS) of -3.91. The EPS decreased by -101.61% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | 0.03 |
VYNT Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to VYNT. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of 37.93% and a revenue growth -100% for VYNT